+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Epidemiology of fungal infections in liver transplant recipients: a six-year study of a large Brazilian liver transplantation centre



Epidemiology of fungal infections in liver transplant recipients: a six-year study of a large Brazilian liver transplantation centre



Memorias do Instituto Oswaldo Cruz 106(3): 339-345



Liver transplant seems to be an effective option to prolong survival in patients with end-stage liver disease, although it still can be followed by serious complications. Invasive fungal infections (ifi) are related to high rates of morbidity and mortality. The epidemiology of fungal infections in Brazilian liver transplant recipients is unknown. The aim of this observational and retrospective study was to determine the incidence and epidemiology of fungal infections in all patients who underwent liver transplantation at Albert Einstein Israeli Hospital between 2002-2007. A total of 596 liver transplants were performed in 540 patients. Overall, 77 fungal infections occurred in 68 (13%) patients. Among the 77 fungal infections, there were 40 IFI that occurred in 37 patients (7%). Candida and Aspergillus species were the most common etiologic agents. Candida species accounted for 82% of all fungal infections and for 67% of all IFI, while Aspergillus species accounted for 9% of all fungal infections and for 17% of all IFI. Non-albicans Candida species were the predominant Candida isolates. Invasive aspergillosis tended to occur earlier in the post-transplant period. These findings can contribute to improve antifungal prophylaxis and therapy practices in Brazilian centres.

(PDF emailed within 0-6 h: $19.90)

Accession: 053009399

Download citation: RISBibTeXText

PMID: 21655823

DOI: 10.1590/s0074-02762011000300014


Related references

Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices. Transplantation 73(1): 63-67, 2002

Pre-transplant cytomegalovirus immunoglobulin G antibody levels could prevent severe cytomegalovirus infections post-transplant in liver transplant recipients: Experience from a tertiary care liver centre. Indian Journal of Medical Microbiology 35(4): 499-503, 2018

Trends in invasive fungal infections over the decade in liver transplant recipients Correlation with evolution in transplantation practices. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 384-385, 2001

Immunosuppression strategies after liver transplantation: a single centre experience in 57 liver transplant recipients. Indian Journal of Surgery 69(5): 187-190, 2007

Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens. Mycoses 58(6): 325-336, 2016

Pre-Transplantation Immune Cell Distribution and Early Post-Transplant Fungal Infection Are the Main Risk Factors of Liver Transplantation Recipients in Lower Model of End-Stage Liver Disease. Transplantation Proceedings 49(1): 92-97, 2017

Primary cytomegalovirus infection in liver transplant recipients: comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study Group. Clinical Infectious Diseases 23(2): 292-297, 1996

Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group. Annals of Internal Medicine 126(4): 275-279, 1997

Infections in live donor liver transplant recipients: A study of timeline, aetiology and antimicrobial resistance of bacterial and fungal infections from the developing world. Indian Journal of Medical Microbiology 35(4): 604-606, 2018

Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: an analysis of the epidemiology, risk factors, and outcomes. Liver Transplantation 19(9): 1011-1019, 2014

Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. American Journal of Transplantation 6(2): 386-391, 2006

Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study. Transplantation 59(1): 45-50, 1995

Fungal infections in liver transplant recipients. Transplantation 40(4): 347-353, 1985

Wound infections in liver transplant recipients Incidence, risk factors, and impact on outcomes The NIDDK liver transplantation database. Hepatology 18(4 PART 2): 324A, 1993

Epidemiology and outcome of infections in HIV/HCV-coinfected liver transplant recipients A FIPSE/GESIDA prospective cohort study. 2011